Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-25-053255
Filing Date
2025-04-11
Accepted
2025-04-11 16:08:21
Documents
20
Period of Report
2025-06-13

Document Format Files

Seq Description Document Type Size
1 PRE 14A qttb-20250411.htm   iXBRL PRE 14A 1315800
2 GRAPHIC img227821089_0.jpg GRAPHIC 32642
3 GRAPHIC img227821089_1.jpg GRAPHIC 32642
4 GRAPHIC img227821089_2.jpg GRAPHIC 1092376
5 GRAPHIC img227821089_3.jpg GRAPHIC 1259384
6 GRAPHIC img227821089_4.jpg GRAPHIC 511012
7 GRAPHIC img227821089_5.jpg GRAPHIC 181547
  Complete submission text file 0000950170-25-053255.txt   10150839

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT qttb-20250411.xsd EX-101.SCH 15224
22 EXTRACTED XBRL INSTANCE DOCUMENT qttb-20250411_htm.xml XML 705581
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Filer) CIK: 0001661998 (see all company filings)

EIN.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38433 | Film No.: 25832144
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)